[go: up one dir, main page]

SE9301171D0 - Pharmaceutical composition containing lipophilic drugs - Google Patents

Pharmaceutical composition containing lipophilic drugs

Info

Publication number
SE9301171D0
SE9301171D0 SE19939301171A SE9301171A SE9301171D0 SE 9301171 D0 SE9301171 D0 SE 9301171D0 SE 19939301171 A SE19939301171 A SE 19939301171A SE 9301171 A SE9301171 A SE 9301171A SE 9301171 D0 SE9301171 D0 SE 9301171D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
composition containing
lipophilic drugs
containing lipophilic
drugs
Prior art date
Application number
SE19939301171A
Other languages
English (en)
Swedish (sv)
Inventor
*Heckenmueller Harald
*Kutz Gerd
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Priority to SE19939301171A priority Critical patent/SE9301171D0/xx
Publication of SE9301171D0 publication Critical patent/SE9301171D0/xx
Priority to AU65146/94A priority patent/AU6514694A/en
Priority to JP6521975A priority patent/JPH08508478A/ja
Priority to NZ263891A priority patent/NZ263891A/en
Priority to BR9406566A priority patent/BR9406566A/pt
Priority to EP94912718A priority patent/EP0693922A1/en
Priority to CN94191658A priority patent/CN1120311A/zh
Priority to SK1198-95A priority patent/SK119895A3/sk
Priority to PCT/SE1994/000258 priority patent/WO1994022426A1/en
Priority to CZ952601A priority patent/CZ260195A3/cs
Priority to FI954767A priority patent/FI954767A7/fi
Priority to CA002159209A priority patent/CA2159209A1/en
Priority to PL94310992A priority patent/PL310992A1/xx
Priority to HU9502933A priority patent/HUT73229A/hu
Priority to IS4145A priority patent/IS4145A/is
Priority to US08/224,164 priority patent/US5514673A/en
Priority to SG1996004517A priority patent/SG52435A1/en
Priority to NO953874A priority patent/NO953874L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SE19939301171A 1993-04-07 1993-04-07 Pharmaceutical composition containing lipophilic drugs SE9301171D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE19939301171A SE9301171D0 (sv) 1993-04-07 1993-04-07 Pharmaceutical composition containing lipophilic drugs
HU9502933A HUT73229A (en) 1993-04-07 1994-03-23 Pharmaceutical composition containing lipophilic drugs
PCT/SE1994/000258 WO1994022426A1 (en) 1993-04-07 1994-03-23 Pharmaceutical composition containing lipophilic drugs
FI954767A FI954767A7 (fi) 1993-04-07 1994-03-23 Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
NZ263891A NZ263891A (en) 1993-04-07 1994-03-23 Pharmaceutical composition of progesterone and/or 17-beta-estradiol, the active ingredient(s) being dissolved in an oil that is the inner phase of an oil-water two-phase system
BR9406566A BR9406566A (pt) 1993-04-07 1994-03-23 Composição farmacêutica uso de progesterona e/ou 17 - - estradiol e processo para a fabricação de uma preparação farmacêutica
EP94912718A EP0693922A1 (en) 1993-04-07 1994-03-23 Pharmaceutical composition containing lipophilic drugs
CN94191658A CN1120311A (zh) 1993-04-07 1994-03-23 含亲脂药的药物组合物
SK1198-95A SK119895A3 (en) 1993-04-07 1994-03-23 Pharmaceutical composition containing lipophilic drugs
AU65146/94A AU6514694A (en) 1993-04-07 1994-03-23 Pharmaceutical composition containing lipophilic drugs
CZ952601A CZ260195A3 (en) 1993-04-07 1994-03-23 Pharmaceutical preparation containing lipophilic therapeutical matters
JP6521975A JPH08508478A (ja) 1993-04-07 1994-03-23 親油性薬物を含有する医薬組成物
CA002159209A CA2159209A1 (en) 1993-04-07 1994-03-23 Pharmaceutical composition containing lipophilic drugs
PL94310992A PL310992A1 (en) 1993-04-07 1994-03-23 Pharmaceutical composition containing lipophylic pharmaceutical substances
IS4145A IS4145A (is) 1993-04-07 1994-03-24 Lyfjablanda sem inniheldur fitusækin lyf
US08/224,164 US5514673A (en) 1993-04-07 1994-04-07 Pharmaceutical composition containing lipophilic drugs
SG1996004517A SG52435A1 (en) 1993-04-07 1994-05-23 Pharmaceutical composition containing lipophilic drugs
NO953874A NO953874L (no) 1993-04-07 1995-09-29 Farmasöytisk preparat inneholdende lipofile legemidler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939301171A SE9301171D0 (sv) 1993-04-07 1993-04-07 Pharmaceutical composition containing lipophilic drugs

Publications (1)

Publication Number Publication Date
SE9301171D0 true SE9301171D0 (sv) 1993-04-07

Family

ID=20389517

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939301171A SE9301171D0 (sv) 1993-04-07 1993-04-07 Pharmaceutical composition containing lipophilic drugs

Country Status (18)

Country Link
US (1) US5514673A (xx)
EP (1) EP0693922A1 (xx)
JP (1) JPH08508478A (xx)
CN (1) CN1120311A (xx)
AU (1) AU6514694A (xx)
BR (1) BR9406566A (xx)
CA (1) CA2159209A1 (xx)
CZ (1) CZ260195A3 (xx)
FI (1) FI954767A7 (xx)
HU (1) HUT73229A (xx)
IS (1) IS4145A (xx)
NO (1) NO953874L (xx)
NZ (1) NZ263891A (xx)
PL (1) PL310992A1 (xx)
SE (1) SE9301171D0 (xx)
SG (1) SG52435A1 (xx)
SK (1) SK119895A3 (xx)
WO (1) WO1994022426A1 (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3470131B2 (ja) 1994-03-16 2003-11-25 大正製薬株式会社 持効性点鼻剤
SE9403389D0 (sv) * 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
CN1044321C (zh) * 1994-11-18 1999-07-28 北京蕾波制药厂 治疗妇女更年期综合征的药物组合物
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
US6599883B1 (en) 1998-10-30 2003-07-29 Nastech Pharmaceutical Company, Inc. Nasal delivery of xylitol
US20020151732A1 (en) * 2001-01-05 2002-10-17 Claes Ohlsson Estrogen receptors
US10004684B2 (en) * 2001-02-14 2018-06-26 Gw Pharma Limited Pharmaceutical formulations
GB2381194A (en) * 2001-09-07 2003-04-30 Gw Pharmaceuticals Ltd Pharmaceutical formulations
FR2827516B1 (fr) * 2001-07-19 2003-09-19 Servier Lab Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone
US20040213837A1 (en) * 2002-08-05 2004-10-28 Sankaram Mantripragada Oil-core compositions for the sustained release of hydrophobic drugs
PL1820494T3 (pl) 2003-06-13 2010-07-30 Skendi Finance Ltd Mikrocząstki składające się z estradiolu i cholesterolu
EP1488785A1 (de) * 2003-06-18 2004-12-22 B. Braun Melsungen Ag Ölemulsion zur postnatalen Hormonsubstitution
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
ATE319426T1 (de) 2003-11-11 2006-03-15 Mattern Udo Nasenformulierung mit kontrollierter freisetzung von sexualhormonen
US8663681B2 (en) * 2005-05-26 2014-03-04 Teva Women's Health, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
CN101237851B (zh) * 2005-06-16 2013-09-18 沃纳奇尔科特有限责任公司 用于阴道给药的雌激素组合物
CN101232869B (zh) * 2005-06-16 2016-03-02 沃纳奇尔科特有限责任公司 局部给药的凝胶组合物
ES2358619T3 (es) 2006-10-04 2011-05-12 M & P PATENT AKTIENGESELLSCHAFT Sistema de administración de liberación controlada para aplicación nasal de neurotransmisores.
TW201138782A (en) * 2010-04-26 2011-11-16 Besins Healthcare Lu Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen
CN101856360A (zh) * 2010-06-08 2010-10-13 玉门中汇农业发展有限公司 一种用于山羊发情调控的孕酮复合制剂
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
EP3145489A1 (en) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
MX2016013693A (es) 2014-07-29 2017-10-31 Therapeuticsmd Inc Crema transdermica.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
EP3435977A4 (en) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. PHARMACEUTICAL COMPOSITION OF STEROID HORMONE
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053489A (en) * 1971-04-21 1977-10-11 Pierre Charles Wirth Oestratriene diethers
US4078060A (en) * 1976-05-10 1978-03-07 Richardson-Merrell Inc. Method of inducing an estrogenic response
US4096254A (en) * 1976-05-10 1978-06-20 Richardson-Merrell Inc. Method of treating the symptoms of menopause and osteoporosis
US4383993A (en) * 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4742046A (en) * 1984-08-03 1988-05-03 Medisearch S.A. Methods and compositions for inhibiting the infectious activity of viruses
IL92496A0 (en) * 1988-12-01 1990-08-31 Schering Corp Compositions for transdermal delivery of estradiol
CA2013755C (en) * 1989-04-05 1993-11-30 Simon Benita Medicinal emulsions
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
CH677886A5 (xx) * 1989-06-26 1991-07-15 Hans Georg Prof Dr Weder
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
US5115805A (en) * 1990-02-23 1992-05-26 Cygnus Therapeutic Systems Ultrasound-enhanced delivery of materials into and through the skin

Also Published As

Publication number Publication date
HU9502933D0 (en) 1995-11-28
NZ263891A (en) 1996-08-27
JPH08508478A (ja) 1996-09-10
WO1994022426A1 (en) 1994-10-13
FI954767L (fi) 1995-10-06
HUT73229A (en) 1996-07-29
FI954767A0 (fi) 1995-10-06
NO953874D0 (no) 1995-09-29
FI954767A7 (fi) 1995-10-06
CA2159209A1 (en) 1994-10-13
SG52435A1 (en) 1998-09-28
CZ260195A3 (en) 1996-01-17
AU6514694A (en) 1994-10-24
US5514673A (en) 1996-05-07
BR9406566A (pt) 1996-02-06
SK119895A3 (en) 1997-03-05
EP0693922A1 (en) 1996-01-31
IS4145A (is) 1994-10-08
PL310992A1 (en) 1996-01-22
NO953874L (no) 1995-09-29
CN1120311A (zh) 1996-04-10

Similar Documents

Publication Publication Date Title
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
BG106030A (en) Pharmaceutical composition
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
FI960032L (fi) Farmaseuttisia koostumuksia vaikeasti liukenevia aktiiviaineita varten
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
ATE427103T1 (de) Orale verabreichung von adenosin analogen
MY100721A (en) Therapeutic agent.
DE69613463D1 (de) Filmbildende pharmazeutische zusammensetzungen zur transdermalen verabreichung
FI960556A7 (fi) Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärje stelmä
IE871584L (en) Sustained release capsule.
FI932553A7 (fi) Uusia farmaseuttisia formulaatioita, jotka sisältävät farmakologisesti aktiivista ionisoitavaa ainetta, sekä menetelmä niiden valmistamiseksi
ATE292453T1 (de) Antivirale arznei
HRP20010684B1 (hr) Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
DE69322251D1 (de) Medizinische zusammensetzung
DE59811768D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
ATE247981T1 (de) Proteinenthaltende pharmazeutische zubereitung
ATE221391T1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
CA2348474A1 (en) Pharmaceutically active composition and dispensing device
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
BR9912260A (pt) Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração
Boulinguez et al. Nicorandil-induced painful aphthae or ulcerations